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Microvascular Decompression for Hemifacial Spasm: Surgical Technical nuances
and results after 300 microvascular decompression surgeries
Abstract
Introduction: Hemifacial spasm (HFS) is characterized by the involuntary, paroxysmal, painless, and
progressive spasmodic contractions of facial muscles innervated by the ipsilateral seventh cranial nerve.
To date, neuroimaging studies (Computed Tomography scan [CT] and Magnetic Resonance Imaging
[MRI]) are unable to establish the diagnosis. HFS medical treatment with antiepileptic drugs, and
Botulinum toxin application are temporarily effective, however, both have shown side effects and lesser
cost-effective results. Currently, surgical Micro Vascular Decompression (MVD) for HFS has the highest
curative rates and lower operative morbidity. We analyze the demographics, clinical manifestations,
outcomes, and complications that to our knowledge, is the largest Latin-American patient’s series treated
for HFS through a keyhole microasterional craniectomy. Objective: The authors report the results of 300
Microvascular Decompression (MVD) for Hemifacial Spasm (HFS) in 265 patients due to nerve attrition
by the neurovascular etiology, triggering of ectopic action potentials from the demyelinated facial nerve
fibers. Methods: We reviewed and analyzed the clinical data from the medical records of patients treated
by MVD for HFS from May 1992 to December 2018. Both preoperative MRI and audiometry studies were
assessed in all patients as part of preoperatively evaluation. Patients with secondary causes of HFS such
as tumors were excluded. Results: Among them, 168 [63.4%] were women and 97 [36.6%] males. 149
(56.2%) HFS were left-sided and with a better outcome compared to the 116 (43.8%) located on right side
(p=0.22). The two main culprit vessels were AICA in 188 (70.9%) followed by PICA in 20 (7.5%). The
basilar artery was identified in 14 (5.3%) and SUCA in 13 (4.9%). Conclusions: MVD through a
retractorless microasterional approach is a very effective and a safe technique for treating HFS. Failure to
HFS improvement after 1-week of MVD warrants immediate reoperation. In addition, MVD is a safe, the
most effective technique and the only curative treatment for HFS.
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Abstract
Introduction: Hemifacial spasm (HFS) is characterized by the involuntary, paroxysmal, painless, and progressive
spasmodic contractions of facial muscles innervated by the ipsilateral seventh cranial nerve. To date, neuroimaging
studies (Computed Tomography scan [CT] and Magnetic Resonance Imaging [MRI]) are unable to establish the diagnosis. HFS medical treatment with antiepileptic drugs and Botulinum toxin application is temporarily effective; however, both have shown side effects and lesser cost-effective results. Surgical microvascular decompression (MVD) for
HFS has the highest curative rates and lower operative morbidity. We analyze the demographics, clinical manifestations,
outcomes, and complications of an HFS patient's series treated through a keyhole microasterional craniectomy that, to
our knowledge, is the most extensive among Latin America.
Objective: The authors report the results of microvascular decompression (MVD) for hemifacial spasm (HFS) due to
nerve attrition by a neurovascular etiology.
Methods: We reviewed and analyzed the clinical data from patients' medical records treated by MVD for HFS from
May 1992 to December 2018. We only included patients with a neurovascular etiology while excluded any other causes
such as tumors. We assessed both preoperative MRI and audiometry studies in all patients as part of preoperative
evaluation.
Results: Two-hundred sixty-ﬁve patients underwent three-hundred MVD for HFS; among them, 168 [63.4%] were females and 97 [36.6%] males. One-hundred forty-nine (56.2%) HFS were left-sided located and one-hundred sixteen
(43.8%) right-sided. The two main culprit vessels were AICA in one-hundred eighty-eight cases (70.9%), followed by
PICA in twenty (7.5%), followed by the basilar artery in fourteen (5.3%), and the SUCA in thirteen (4.9%).
Conclusions: MVD through a retractor-less microasterional approach is a very effective and safe technique for treating
HFS. In addition, MVD is the only curative treatment for HFS; therefore, failure to improve after 1-week of MVD
warrants immediate reoperation for HSF.
Keywords: Hemifacial spasm, Microvascular decompression, Asterional approach

1. Introduction

H

emifacial spasm (HFS) is characterized by
involuntary, paroxysmal, painless, and progressive spasmodic contractions of facial muscles

innervated by the ipsilateral seventh cranial nerve
[1e10]. HFS tends to be predominantly left-sided
and to have a 2:1 preponderance ratio over the female gender [11,12]. The HFS prevalence has been
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reported in 10 cases/100,000 people [13,14] being
primarily patients over the ﬁfth decade of life [6,11].
HFS is classiﬁed as typical and atypical [11,12,15]
according to the initial twitching manifestation and
rendering to the occurrence in the superior or
inferior half of the face, respectively. While untreated, the overall tendency is to worsen over time
[4,9] with the potential to develop various grades of
facial palsy [16,17]. HFS is referred to as "tic
convulsive" when co-occurring with trigeminal
neuralgia (TN), as Cushing's ﬁrst description in 1920
[18]. Though HFS occurs unconsciously, it can be
elicited by triggering maneuvers and psychogenic
stimuli [4,11,19]. Even though HFS contractions
decrease during rest, HFS and palatal myoclonus
persist during sleep [2,20e23]. Medical treatment
with carbamazepine, clonazepam, and gabapentin
can only achieve poor and transient improvement
[9,24,25]. Botulinum toxin type A in HFS has shown
improvement of 75e100% [26,27]; however, beneﬁcial effects are temporary and periodic applications
are required [3,5,9,24]. In addition, botulinum toxin
type A is not innocuous, carries potential side effects, and has a lesser cost-effective result [9,28e30].
The clinical features of HFS at examination (e.g.,
facial twitching) are keys for the diagnosis; however,
ancillary tests such as electromyography (EMG) can
also be of help [24,25,31]. Neuroimaging studies
alone cannot establish the diagnosis; nevertheless,
computed tomography scan (CT-scan) [25,32,33],
magnetic resonance imaging (MRI) [4,24,34e39],
and hemodynamic studies [40] are valuable tools to
rule out posterior fossa pathology other than
vascular compression. Authors have hypothesized
the mechanism of HFS to be the result of the pulsatile cross-compression over the seventh (facialVII) within the Root Entry/Exit Zone (REZ) by 1 or 2
arterial loops [3e5,34] causing an ephaptic transmission between individual nerve cells ﬁbers
dropped the excitability threshold of the neurons in
the compression zone [31,41,42]. The Anterior Inferior Cerebellar Artery (AICA) [3,43] and the Posterior Inferior Cerebellar Artery (PICA) [44e46], are
considered the main culprit vessels involved in the
compression, varying its frequency depending on
the series.
Since Jannetta established and popularized the
MVD technique in the 1970s [17,44,46e48], technical
improvements have allowed other surgeons to
perform MVD with minimally invasive approaches
[12,20,25,38,44,49,50]. Currently, MVD for HFS has
cure rates up to 90% and operative morbidity of less
than 10% [11,30,51,52] being the only curative option
that "treats" the cause of HFS hemifacial spasm.
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Abbreviations
MVD
MRI
TN
REZ
AICA
PICA
SUCA
EMG
CT
NINN
HB
CPA
CSF
SD
IQR
BAEP
FIESTA

Micro Vascular Decompression
Magnetic Resonance Imaging
Trigeminal Neuralgia
Root Entry Zone
Anterior Inferior Cerebellar Artery
Posterior Inferior Cerebellar Artery
Superior Cerebellar Artery
Electromiography
Computed Tomography
National Institute of Neurology and Neurosurgery
House Brackman
Cerebello pontine angle
Cerebrospinal ﬂuid
Standard Deviation
Inter Quartile Range
Brainstem Auditory Evoked Potentials
Fast Imaging Employing Steady-State Acquisition

This study aims to analyze the demographics,
clinical manifestations, outcomes, and complications
of an HFS patient's series treated through a keyhole
microasterional craniectomy that, to our knowledge,
is the most extensive among Latin America.

2. Patients and methods
We reviewed and analyzed the clinical data and
medical ﬁles of patients treated with MVD for HFS
from May 1992 to December 2018; we made this study
in adherence to STROBE guidelines for retrospective
observational cohorts. We only included patients
with a neurovascular etiology while excluded any
other causes such as tumors. We assessed both preoperative MRI and audiometry studies in all patients
as part of preoperative evaluation. Our institutional
ethics board approved this study.
2.1. Data collection and follow-up
We collected data including age, sex, previous
medical history, duration of HFS, previous nonsurgical treatments, complications, and presence or
absence of HFS at the time of hospital discharge.
HFS outcome was set on the relief of symptoms and
classiﬁed according to the previously described
Revuelta's HFS score-criteria [12,53] (see Table 1):
"Spasm free" group, grades I (Excellent) and II
(Good); and 2) "Spasm-relapse," grades III (bad)
and IV (recurrence). In addition, we also registered
surgical ﬁndings such as the offending vessel,
intraoperative photos, or video recordings for each
case. All patients were followed for at least six
months after surgery on consecutive assessments at
the outpatient clinic.
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Table 1. Revuelta's HFS grading score and present study immediate postoperative results after 300 MVD
Grade

Deﬁnition

n (%)

I e Excellent

Complete HFS cessation or 2 muscle spasms per week, or a
sensation of facial twitching that not visible by observers
1 or 2 muscle spasms per day, with remarkable preoperative
improvement
More than 2 muscle spasms per day, with slight preoperative improvement or HFS unchanged after surgery
Relapse or reappearance of symptoms after initial resolution, excellent or good response

222 (83.8)

II e Good
III e Bad
IV e Recurrence*

11 (4.2)
32 (12)
29 (10.1)

*Patients with previous grades I/II at discharge with recurrence within 6-month postoperative period.

All surgeries were performed by a senior Neurosurgeon (R.R.G), excluding potential bias related to
surgeon skills and experience [55].

occipitomastoid sutures. According to Rhoton's
technique, we used the asterional burr-hole, as this
method reduces the risk of lacerating the sinus
complex in the posterior part of the parietomastoid
suture, which is related to the transverse sinus's
superior margin and its transition to the sigmoid
sinus. From 1998 on, we used only one burr hole
placed two centimeters below the asterion, twothirds behind and one-third in front of the occipitomastoid suture. Under this technique, the microasterional keyhole craniectomy (2.5e3 cm) lays just
below the inferior recess of the ipsilateral transverse
sinus. Additionally, we applied wax vigorously over
the edges to ﬁll the defect when we opened mastoid
air cells.

2.3. Patients position

2.6. Dural opening

We performed all MVDs under general anesthesia
and park bench positioning with the head ﬁxed in a
Mayﬁeld skull clamp. After ventral and caudal
shoulder retraction, the head was rotated 60
opposite the HFS side with a slight lateral tilt of
approximately 15 towards the ﬂoor to allow an
optimal surgical corridor through the seventh nerve
REZ as reported previously [56e58].

We performed a dural "C" shaped incision
(1.5e2 cm) with the base at the transverse-sigmoid
sinus junction to achieve the optimal dural angle
exposure between tentorium and petrous surface
[56e58]. Thus, when we correctly placed the
microasterional craniectomy and correctly opened
the dural, we did not need stitches to access
both the CPA and infratentorial/supracerebellar
corridors.

Postoperative complications that recovered spontaneously within the ﬁrst 6-months after surgery
were assigned as "transient" and "permanent"
when persisted after six months. We used the
House- Brackmann (HB) score to establish the facial
palsy grade, while we assessed hearing loss
comparing to a preoperative audiological evaluation
[54]. In both cases, we measured the duration of
symptoms after MVD.
2.2. Technical nuances and surgical technique

2.4. Transverse and sigmoid sinus projection
We ﬁrst identiﬁed the landmarks, including the
inion, the mastoid tip and notch, and a projection of
the transverse sinus using Reid's baseline. We then
performed a small (5 cm approximately) curvilinear
rectosigmoid skin incision 3 cm behind the posterior
ear (or 4.5 cm behind external acoustic meatus) over
the transverse sinus projection. Next, we conducted
a subperiosteal muscle dissection using sharp
square periosteal elevators and monopolar
(BovieTM) coagulation.
2.5. Microasterional craniectomy
The asterion is a landmark representing the
junction of the lambdoid, parietomastoid, and

2.7. Intradural dissection
To amplify the operative ﬁeld, we directed highly
hydrated cottonoid patties rostrocaudally to allow
drainage of the CSF. After sharp dissection of
arachnoid membranes, we facilitated cisternal
release by meticulous CSF depletion; then, the
operative corridor is retractor-less opened using
both the suction tube and bipolar electrocautery
over soggy patties taking advantage of gravity. After
optimal cerebellar relaxation, the cerebellum falls
away from the petro-tentorial junction. Using the
infraﬂoccular corridor, we could observe the
pathway of the cisternal segment of the facial nerve
from REZ to its bony entrance at the internal auditory canal.
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2.8. Microvascular decompression

Table 2. Clinical characteristics and preoperative ﬁndings of the Study
Patients.

After visualization of neurovascular conﬂicts, we
conﬁrmed the diagnosis, proceeding to move the
offending vessels away using microsurgical dissectors on the left and off-bipolar on the right hand.
After we identiﬁed the conﬂict zone, we applied one
to three Teﬂon felt pledgets. When we observed no
evidence of vascular contact on the seventh-nerve
(n ¼ 12 patients), instead of Teﬂon threads placement, we used very subtle compression over the
REZ of the facial nerve using the off-bipolar for no
more than ﬁve seconds. Finally, we closed the dura
mater with a watertight technique.

Characteristics

2.9. Statistical analysis
We analyzed categorical variables using descriptive statistics (frequencies and percentages). For
continuous variables, we used dispersion measures
(means and SD). In addition, we used the student Ttest to compare pre and postoperative status and
outcomes between groups. Lastly, we performed a
factorial regression analysis to identify preoperative
risk factors.

3. Results
3.1. Demographics results
From May 1992 to December 2018, we collected
265 consecutive patients with diagnosis HFS
admitted to the Department of Neurosurgery at
NINN. Among them, 168 [63.4%] were women and
97 [36.6%] males. One-hundred forty-nine cases of
HFS (56.2%) were left-sided, and one-hundred
sixteen (43.8%) were right-side. Table 2 shows other
additional demographic characteristics.
3.2. Preoperative clinical ﬁndings
Only four (1.5%) patients had a preoperative HB
score of 2; the remaining two hundred sixty-one
(98.5%) were grade 1. Concerning their HFS symptoms onset, two hundred thirty-seven (89.4%)
typical HFS began in the lower eyelid progressing
downwards to oral commissure, while twenty-eight
atypical HFS (10.6%) had mouth muscles initially
affected with spreading upwards. All the patients
received an audiometric evaluation (n ¼ 265); two
hundred thirty-one (87.2%) of them had a normal
result, while thirty-ﬁve (12.8%) were abnormal
(Table 2). Because our institution is public and a
national reference center, we performed brainstem
auditory evoked potentials (BAEP) selectively in two

Total
(N ¼ 265)

Age (years)
50.4 ± 12.7
Sex
Male
97 (36.6%)
Female
168 (63.4%)
*Spasm side
Right
116 (43.8)
Left
149 (66.2)
Type of Spams
Typical
237 (89.4)
Atypical
28 (10.6)
Botulinum Toxin
No
231 (87.2)
Yes
34 (12.8)
Previous Surgery
Yes
3 (1.1)
No
262 (98.9)
*BSAP
Normal
172 (64.9)
Abnormal
35 (35.1)
Audiometry
Normal
231 (87.2)
Abnormal
34 (12.8)
Type of Approach
Asterional
247 (93.2)
Jannetta
18 (6.8)
Vessel in MRI
No
115 (43.4)
Yes
150 (56.6)
Vessel
None
12 (4.5)
SUCA
13 (4.9)
AICA
188 (70.9)
PICA
20 (7.5)
Basilar
14 (5.3)
More than one 18 (6.8)
Type of Material
Dacron
10 (3.8)
Silastic
15 (5.7)
Teﬂon
240 (90.6)

Free of HFS Failure
(n ¼ 233)
(n ¼ 32)

P Value

50.0 ± 12.2 53.63 ± 15.6 0.133
0.78
86 (88.7)
11 (11.3)
147 (87.5)
21 (12.5)
*0.022
108 (93.1)
8 (6.9)
125 (83.9)
24 (16.1)
0.124
211 (89.0)
26 (11.0)
22 (78.6)
6 (21.4)
1.0
203 (87.9)
28 (12.1)
30 (88.2)
4 (11.8)
1.0
3 (100)
0 (0)
230 (87.8)
32 (12.2)
0.583
152 (88.4) 20 (11.6)
30 (85.7) 5 (14.3)
*0.044
207 (89.6) 24 (10.4)
26 (76.5) 8 (23.5)
0.7
216 (87.4) 31 (12.6)
17 (94.4) 1 (0.6)
104 (90.4) 11 (9.6)
129 (86.0) 21 (14.0)
0.4
12 (100)
13 (100)
165 (87.8)
17 (85.0)
11 (78.6)
15 (83.3)

0 (0)
0 (0)
23 (12.2)
3 (15)
3 (21.4)
3 (16.7)

7 (70.0)
3 (30.0)
11 (73.3) 4 (26.7)
215 (89.6) 25 (10.4)

*Statistically signiﬁcant. Abbreviations: SD¼ Standard Deviation,
IQR¼
Interquartile
range,
CBZ¼Carbamazepine,
PHT ¼ phenytoin. * Tic convulsive deﬁned as HFS concomitant
with Trigeminal Neuralgia.

hundred-seven patients that could afford the extra
cost involved. BAEP was normal in one hundred
seventy-two (83.1%) and abnormal in thirty-ﬁve
(16.9%). Table 2 shows the summary of other
essential preoperative clinical ﬁndings.
3.3. Preoperative MRI and neuro-radiological
reports
All the two hundred sixty-ﬁve patients were
evaluated with a 1.5 T MRI (Siemens) using T1/T2
weighted sequences to rule out other posterior fossa
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pathology rather than the suspected microvascular
compression over the seventh nerve. Additionally,
we performed fast imaging employing steady-state
acquisition (FIESTA) sequence preoperatively to
assess CSF within dural reﬂections of VII-VIII cranial nerves in all the patients. Brain-MRI was reported as normal in one hundred ﬁfteen (43.4%) of
the patients, and the offending vessel was presumptively identiﬁed in one hundred ﬁfty (56.6%) of
the patients (see Table 2).
3.4. Surgical results
A total of three hundred patients underwent
MVDs (two-hundred sixty-ﬁve ﬁrst-time surgery
and thirty-ﬁve reinterventions) in two-hundred
sixty-ﬁve patients in 26 years (Fig. 1).
3.5. Offending vessels and surgical ﬁndings
We identiﬁed a total of two hundred ﬁfty-three
offending vessels. The two main culprit vessels

were AICA in one-hundred eighty-eight of the
cases (70.9%), PICA in twenty (7.5%), the basilar
artery in fourteen (5.3%), and SUCA in thirteen
(4.9%). Compression by two different "loops" originated from different vessels was seen in eighteen
(6.8%), while we found no offending vessel in
twelve (4.5%) patients. We used Teﬂon two-hundred forty (90.6%) of the patients, which we
consider the preferred material (after 1995) because
of its ease of use, price, and maneuverability (see
Table 3). Table 2 shows the remaining postoperative
results.
3.6. Postoperative HFS-relief outcomes
In the whole two-hundred sixty-ﬁve patient
cohort, we discontinued all conservative treatments
after surgery. We performed a total of three hundred MVDs was performed, two-hundred sixty-ﬁve
(88.3%) were ﬁrst-time surgery; meanwhile, thirtyone (10.3%) patients needed a ﬁrst reintervention,
and among them, only four (1.3%) underwent a

National Institute of Neurology and
Neurosurgery (1992 – 2018)
300 MVD performed for HFS

According to Revuelta’s
HFS grading scale

Grade II

Grade I

5

Patients who underwent
first MVD surgery

n=265 patients

Grade III

Patients who underwent
second MVD surgery

n=31 patients

Persistent Grade III at
Revuelta’s grading scale
after second surgery

Persistent Grade III at
Revuelta’s grading
scale after surgery

n=4 patients
Fig. 1. Flow Chart of patients who underwent MVD. *Grade IV was omitted due was applicable after six months of follow-up.
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Table 3. Postoperative complications.
Complications (n, %)
CN VI-related complication
Diplopia
CN VII-related complication
Facial palsy
CN VIII-related complication
Hearing decrease
Deafness
Vertigo
Tinnitus
Others
CSF leakage
Wound infection
Total*
HFS recurrence that diminished
and had spontaneous relapse after
one year follow-up

Transient

Permanent

Total

1 (0.3)

0 (0)

1 (0.3)

36 (12)

9 (3)

45 (15)

15 (5)
0 (0)
13 (4.3)
4 (1.3)

6
2
0
3

21 (7)
2 (0.6)
13 (4.3)
7 (2.3)

7 (2.3)
5 (1.7)
81 (27)
27 (9)

0 (0)
0 (0)
20 (6.6)
2 (0.6)

(2)
(0.6)
(0)
(1)

7 (2.3)
5 (1.7)
101 (33.6)
29 (9.6)

*Statistically signiﬁcant. Abbretiatons: AICA ¼ Anterior Inferior Cerebellar Artery, PICA¼ Posterior Inferior Cerebellar Artery, SUCA¼
Superior Cerebellar Artery.

second reintervention due to the persistence of HFS.
For those who were re-operated, we saw no material
migration either at ﬁrst or second reintervention.
Only three (1.1%) patients were previously surgically treated in other hospitals from the complete
patient's sample. The immediate postoperative HFS
relief according to Revuelta's HFS grading score
results is displayed in Table 1. On the twelve patients whom a neurovascular conﬂict was not
demonstrated, we obtained excellent results in 9
(75%), good in 2 (16.7%), and bad in only 1 (8.3%)
patient after both the appliance of Teﬂon threads
and very light compression with bipolar over seventh's nerve REZ for no more than 5 s.
3.7. Complications
Postoperative facial weakness was more common
than hearing loss. Facial palsy was found in 45 (15%)
at postoperative day 1 (HB5 and 4) with a recovery

rate of 80% in the ﬁrst 6-months of follow-up. We
could not identify the offender vessel in 12 patients
requiring light compression with the off-bipolar at
seventh's nerve REZ; from them, four patients
developed an HB 2, and one patient developed an
HB 3 with hearing decrease with full recovery 6months of follow up period. Hearing decrease was
found in 21 patients (7%); among them, 15 patients
had full hearing function recovery after 6-months of
follow-up, six patients continued with a non-useful
hearing by audiometry after a 1-year follow-up, and
two (0.6%) with deafness. We had only one patient
with diplopia who recovered spontaneously in 3
months after surgery. Table 3 demonstrates the information regarding other complications. We
treated CSF leakages with external lumbar drainage
showing complete resolution after the ﬁfth day.
Wound infections were entirely resolved with
intravenous antibiotics demonstrating consecutive
negative cultures within two weeks. Twenty-nine

Table 4. Logistic regression analysis for complications after 300 MVD for HFS.
Prognostic Factors

Age (years)
Sex
Spasm side
Type of Spams
Botulinic Toxin
Previous Surgery
BSAP
Audiometry
**Type of Approach
Vessel
Type of Material
Culprit vessel in MRI*

P Value

0.088
.932
.387
.356
.588
1.000
.185
.803
.063
.54
.259
0.003

Odds Ratio

.973
1.305
1.577
1.310
.000
1.859
.884
4.804
1.698
.483
.683

95% CI
Inferior Limit

Superior Limit

.514
.714
.600
.493
.000
.743
.335
.921
1.202
.230
.352

1.839
2.383
4.147
3.478
.
4.648
2.330
25.060
2.399
1.013
1.325

*Statistically signiﬁcant, ** Microasterional approach after 1998, and Retrosigmoid approach before 1998 were used.

patients (12.4%) presented recurrence of a grade IV
HFS after a previous grade I or II within the initial
six months to 2-years after the initial surgery.
However, we performed no additional surgical
intervention because spasms diminished spontaneously and attained quiescently. Table 4 shows the
analysis of complications after the logistic regression; identifying a culprit vessel previous to surgery
was the only factor statistically signiﬁcant with a
p ¼ 0.003.

4. Discussion
The estimated incidence of HFS is 0.8 cases per
100,000 individuals with a 2:1 female preponderance
ratio and a prevalence reported in 14.5 women per
100,000 cases and 7.4 males per 100 000 cases
[4,6,11,25]. Since the ﬁrst case of HFS described in
the literature by F. Shültze in 1875, the hallmark of
this entity has been the involuntary, paroxysmal,
left-sided, and painless contractions of the muscles
innervated by the facial nerve in middle-aged
women [3,11,13,24,25].
Contrastingly to its unilateral nature (hemi ¼ one
side), there exist bilateral HFS cases [10,15,34,61,62]
and HFS in patients under 30-year, as the so-called
"young-onset HFS” [6,63,64]. In our study, the
afﬂicted patients were predominantly females
(63.4%) over the fourth and ﬁfth decade of life, and
with a slightly left-side apparition (56.2%), these
results are consistent with the HFS current literature
reported [3,4,7,9,11,46].
Typical HFS symptoms start on the lower eyelid
and periorbital musculature but later involve the
ipsilateral facial, perioral, and platysma muscles
over months to years [1,11]. On the other hand,
patients with atypical syndrome start instead on the
lower half of the face [11,12,15]. Like other series, we
found the "typical" syndrome onset as the most
common HFS in two-hundred thirty-seven (89.4%),
while ﬁnding "atypical" syndrome in twenty-eight
(10.6%). We found only twelve (4.5%) patients with
"tic convulsif" or "tic dolorous," as the initially
Cushing's description at 1920 when HFS is coexisting with TN [18,59].
Although in practice, the underlying HFS etiology
is the nerve attrition due to an atypically aberrant
blood vessel, two main theories explain the pathophysiology of HFS. The "peripheral" hypothesis
stands that the neurovascular interface triggers
ephaptic and ectopic action potentials from the
locally demyelinated facial nerve ﬁbers by surrounding arterial loops, which compresses the facial
nerve within or close to the REZ [3e5,23,34]. The
opposite
"central"
hypothesis
stands
that
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hyperexcitability arises from the facial motor nucleus in the brainstem [3]. HFS diagnosis is easy to
ascertain clinically by simple observation of the
patient's face; however, it is frequently confused
with other facial movement disorders. Neurodiagnostic studies are rarely helpful in HFS. Recent
evidence suggests that MRI should be performed
when possible using a 3T magnet due to signal-tonoise and contrast-to-noise ratios better at 3T than
lower ﬁeld strengths [35]. However, neuroimaging
studies have also found nerve conﬂicts at VII/VIII
nerve complex in asymptomatic patients [36,37]. The
anatomic conspicuity of the posterior fossa and the
poor delineation of cranial nerves on image studies
complicate small vessels' assessment. Surprisingly,
the interobserver discrepancy and differences between image studies concerning the conﬂict vessels
reported preoperatively in HFS on MRI studies
correlate purely with the actual vessels seen at
surgery compressing the VII nerve [5]. From one
hundred ﬁfty patients' studies with an abnormal
MRI, we found that ninety-eight (37%) of them reported a non-speciﬁc vascular loop, and forty-seven
(17.7%) reported a dolichoectatic basilar artery;
while ﬁve (1.9%) only reported an "abnormal MRI."
MRI-angiography may demonstrate the vascular
features around the root entry zone [11]. Although a
CT or MRI screening imaging study may not be
justiﬁed in all cases of HFS, it is prudent to employ
these diagnostic studies in all atypical cases to rule
out tumoral pathology rather than an accurate
compression over a speciﬁed vessel.
Our experience with these patients has led us to
think that long-standing disease and delay in surgical treatment frequently lead to social isolation. As
the diagnosis can be difﬁcult, a psychogenic stimulus such as emotional stress, repetitive face
movements, and even speaking can elicit and
trigger spasms, helping in differentiate them from
other facial movements disorders such as blepharospasm, oromandibular dystonia, facial tic, hemimasticatory spasm, myokymia, and facial myorhythmia [4,10,19,27]. HFS, along with palatal myoclonus, is the only two-movement disorder that
persists during sleep [2,20e23].
Rather than surgery, other therapeutic options
consider oral medications, acupuncture, and botulinum toxin type A injections [9,24,27]. The subcutaneous injections with botulinum toxin type A on
the facial affected muscles produce complete or
almost complete relief of symptoms in 76e100% of
patients [28,65]; however, the improvement is only
temporary (mean duration, 3e6 months). In addition, despite the effectiveness of botulinum toxin
injections can be maintained for years to alleviate
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the symptoms of HFS, it represents a less costeffective treatment due to dosage that may need to
be gradually increased to achieve its desired effect
[9,28]. In this series, we found the main alternative
conservative treatment received was botulinum
toxin type A in thirty-four (12.8) patients, followed
by CBZ and PHT in twenty-one (7.9%). Furthermore, we saw a mean of three years delay before
MVD as deﬁnitive treatment among those who
received botulinum toxin type A.
In Mexico, applying a single botulinum toxin injection for HFS cost between 5500 and 7300 Mexican
pesos (275e365 US Dollars). This cost includes
medical fees, botulinum toxin bottle (AllerganTM)
at each session. Nevertheless, one patient with HFS
needs approximately four sessions, summing a total
of 22,000e29,200 Mexican pesos (1100e1460 US
Dollars) for optimal relief for three months. On the
other side, in our hospital, the mean individual
payment for MVD for HFS is 3000 Mexican pesos
(150 USD), including surgery, doctor fees, and inhospital care for three postoperative days.
The only curative treatment and HFS long-term
control that treats the cause of HFS has been the nerve
decompression of the culprit's vessel on REZ
[17,38,45]. This zone, also called the ObersteinerRedlich zone, corresponds with a transitional zone
between central and peripheral myelin. HFS has
excellent clinical results after MVD when performed
by a neurosurgeon who has experience in the nuances of the operative procedure; however, newer
MVD technique has been strengthened over time by
the endoscope integration in the so-called endoscope-assisted (EA) surgery. When combined, EA
procedures bring inherent endoscope's advantage in
"looking around the corner." Other advantages in
using EA are avoidance of cerebellar retraction in
patients with complicated or abnormal posterior
fossa anatomy where the microscope's view alone
limits identiﬁcation of neurovascular conﬂicts [66,67].
In the present series, we found the anterior inferior cerebellar artery (AICA) as the primary culprit
vessel in one hundred eighty-eight (70.9%)
[3,9,12,43,68]; however, others have reported the
posterior inferior cerebellar artery (PICA) as the
most common vessel responsible [17,40,44,45,69]
(PICA twenty (7.5%) in our series). More rarely, vein
compressions as etiology for HFS have also been
described [69,70]. Interestingly, although most
nerveevascular complexes responsible for HFS are
either rostrocaudally or ventrocaudal at the REZ or
brainstem, a blood vessel on the posterior or rostral
side of the nerve could cause the atypical HFS;
however, these ﬁndings were not statistically signiﬁcant in this case series.
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Sindou et al., in 2018 reported a variety of grading
scales for assessing the outcome after MVD for HFS
[52]; however, returning to the patient's selfassessed previous everyday life is the best indicator
that impacts the ﬁnal outcome. Therefore, the patient's HFS relief appreciation is the best indicator
that the surgeon could achieve (RRG).
The overall consensus for reoperation in recurrent
HFS after MVD has been set to 12 months [52].
However, the senior surgeon's opinion (RRG) is that
patients with recurrent symptoms in the ﬁrst four
days after surgery require immediate exploration,
and those with later recurrence without facial
paresis are likely to improve within the next six
months to 2 years. Although HFS is painless and
non-life-threatening, HFS affects facial appearance;
the cosmetic and aesthetic discomfort becomes socially and frequently economically disabling [46]. In
severe cases, the facial disﬁgurement generates high
anxiety levels with potentially psychiatric complications that could directly impact self-image and
satisfaction [9]; this severe condition requires timely
diagnosis and therapy [24]. In the MVD, as in the
rest of Neurosurgical procedures, high precision
preoperative planning is mandatory.
This series is the largest to date on a Hispanic
population. In high-volume centers with experienced Neurosurgeons, the MVD for HFS through a
microasterional craniectomy approach constitutes a
reliable surgical treatment at which it is possible to
achieve optimal exposure of the central aspect of the
CPA. The main challenge is the limited microsurgical working space to achieve a successful decompression and optimal brain stem structures [45]. In
addition, the microasterional craniectomy approach
is minimally invasive, nondestructive, and achieves
good long-term results with minor morbidity.
This study has two limitations. First, we did not
use intraoperative EMG and BAEP due to the cost
involved. Electrophysiological monitoring is a
valuable tool in MVD surgeries, such as monitoring
the abnormal muscle response (AMR) while evaluating the offending vessels and ensuring adequate
decompression, or by BAEP monitoring to reduce
the incidence of hearing impairment [71]. Unfortunately, this circumstance prevented us from
observing an association between neurophysiological studies and postoperative deﬁcits. Second, the
inherent limitations of retrospective, single-center
investigations. The main delay in receiving surgical
treatment was over-population at our institution
and the surgical cost involved. We did not compare
MVD effectiveness over patients only treated with
botulinum toxin in a control group. Extensive
studies are lacking that compare the possible

therapeutic options in randomized and controlled
trials. Despite these limitations, we recommend that
surgery be deliberately decided, especially in the
early stages, and immediate reoperation in spasm
relapse within 1-week of surgery.

5. Conclusions
Due to the recent technological advancements in
microsurgery, extensive craniotomies have been
replaced by less invasive keyhole craniotomies. We
have found that the patients' age, gender, pathology
side, and the time from onset of symptoms are nonrelated factors in achieving a good outcome after
MVD in HFS after surgical treatment.
The use of alternative treatments, different from
surgical, tends to worsen HFS over a variable
period. While non-life-threatening, HFS can significantly affect the quality of life.
In well-trained hands, MVD through a retractorless microasterional approach is an effective and
safe technique for treating HFS; in addition, MVD is
the only curative treatment for HFS. Therefore,
failure to HFS improvement after 1-week of MVD
warrants immediate reoperation.
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